DK83889A - Anvendelse af laegemiddel til hindring af intraventrikulaer bloedning hos for tidligt foedte boern - Google Patents

Anvendelse af laegemiddel til hindring af intraventrikulaer bloedning hos for tidligt foedte boern

Info

Publication number
DK83889A
DK83889A DK083889A DK83889A DK83889A DK 83889 A DK83889 A DK 83889A DK 083889 A DK083889 A DK 083889A DK 83889 A DK83889 A DK 83889A DK 83889 A DK83889 A DK 83889A
Authority
DK
Denmark
Prior art keywords
prevention
medicinal product
early birth
children
intraventricular
Prior art date
Application number
DK083889A
Other languages
English (en)
Other versions
DK174978B1 (da
DK83889D0 (da
Inventor
Akira Shirahata
Minoru Uchida
Satoshi Tanaka
Kenichiro Tsumura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK83889D0 publication Critical patent/DK83889D0/da
Publication of DK83889A publication Critical patent/DK83889A/da
Application granted granted Critical
Publication of DK174978B1 publication Critical patent/DK174978B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK198900838A 1988-02-24 1989-02-23 Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn DK174978B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63039646A JPH01216939A (ja) 1988-02-24 1988-02-24 末熟児頭蓋内出血阻止剤
JP3964688 1988-02-24

Publications (3)

Publication Number Publication Date
DK83889D0 DK83889D0 (da) 1989-02-23
DK83889A true DK83889A (da) 1989-08-25
DK174978B1 DK174978B1 (da) 2004-04-05

Family

ID=12558846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900838A DK174978B1 (da) 1988-02-24 1989-02-23 Anvendelse af human koagulationsfaktor XIII til fremstilling af et lægemiddel til hindring af intraventrikulær blødning hos for tidligt fødte børn

Country Status (12)

Country Link
US (1) US5114916A (da)
EP (1) EP0330049B1 (da)
JP (1) JPH01216939A (da)
KR (1) KR0137476B1 (da)
AT (1) ATE94070T1 (da)
AU (1) AU613154B2 (da)
CA (1) CA1332352C (da)
DE (1) DE68908913T2 (da)
DK (1) DK174978B1 (da)
ES (1) ES2059588T3 (da)
IE (1) IE63656B1 (da)
PT (1) PT89802B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
CA2127107C (en) * 1991-12-31 2007-06-19 Bruce L. A. Carter Methods and compositions for reducing blood loss
WO1993020837A1 (fr) * 1992-04-21 1993-10-28 Ajinomoto Co., Inc. Remede contre les plaies
DK0669834T3 (da) * 1992-11-12 2000-04-17 Zymogenetics Inc Anvendelse af topisk påført faktor Xlll til inhibering af blødning
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
ATE498409T1 (de) 1998-08-06 2011-03-15 Mountain View Pharmaceuticals Peg-uricase konjugate und verwendung davon
CN101010333B (zh) * 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
CA2587139C (en) * 2004-11-23 2014-05-27 Zymogenetics, Inc. Purification of recombinant human factor xiii
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
SG161247A1 (en) 2005-04-11 2010-05-27 Savient Pharmaceuticals Inc Variant forms of urate oxidase and use thereof
JP5033177B2 (ja) * 2006-04-12 2012-09-26 サビエント ファーマセウティカルズ インク． 陽イオン界面活性剤によるタンパク質の精製
US9377454B2 (en) 2009-06-25 2016-06-28 Crealta Pharmaceuticals Llc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
CN116637177A (zh) 2016-11-11 2023-08-25 好利恩治疗美国公司 泼尼松和尿酸酶分子的组合疗法及其用途
WO2020160322A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
DE2063070C3 (de) * 1970-12-22 1975-07-24 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Arzneimittels mit fibrinstabilisierender Wirkung
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
EP0268772B1 (en) * 1986-09-19 1995-04-26 ZymoGenetics, Inc. Expression of biologically active factor XIII

Also Published As

Publication number Publication date
EP0330049B1 (en) 1993-09-08
DE68908913T2 (de) 1994-01-27
JPH0378850B2 (da) 1991-12-17
DK174978B1 (da) 2004-04-05
KR0137476B1 (ko) 1998-06-01
IE890580L (en) 1989-08-24
ATE94070T1 (de) 1993-09-15
KR890012659A (ko) 1989-09-18
EP0330049A2 (en) 1989-08-30
US5114916A (en) 1992-05-19
AU3024389A (en) 1989-08-24
EP0330049A3 (en) 1991-01-30
JPH01216939A (ja) 1989-08-30
ES2059588T3 (es) 1994-11-16
DE68908913D1 (de) 1993-10-14
PT89802A (pt) 1989-10-04
CA1332352C (en) 1994-10-11
IE63656B1 (en) 1995-05-31
PT89802B (pt) 1994-04-29
AU613154B2 (en) 1991-07-25
DK83889D0 (da) 1989-02-23

Similar Documents

Publication Publication Date Title
DK83889A (da) Anvendelse af laegemiddel til hindring af intraventrikulaer bloedning hos for tidligt foedte boern
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
NO875299D0 (no) Insulinpreparat for ikke-paranteral administrasjon.
ATE87484T1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2073425T3 (es) Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.
NO904378L (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
DK678887D0 (da) Farmaceutiske praeparater
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
Di Cato “Purple toes” syndrome: An uncommon complication of oral anticoagulant therapy
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
KR910015294A (ko) 약제 조성물
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.

Legal Events

Date Code Title Description
PUP Patent expired